A phase II study of MabCampath [alemtuzumab] combined with fludarabine in patients with refractory B-cell chronic lymphocytic leukaemia
Latest Information Update: 04 Aug 2005
At a glance
- Drugs Alemtuzumab (Primary) ; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 04 Aug 2005 New trial record.